At LUCIUS PHARMACEUTICALS (LAO) CO., LTD, our mission is to deliver advanced, reliable therapies that make a real difference in patients’ lives. One of the key treatments we provide is Mitotane—a specialized medication developed for patients diagnosed with adrenal cortical carcinoma (ACC), a rare and challenging form of adrenal gland cancer.
What is Mitotane?
Mitotane is an oral targeted therapy created specifically for adrenal cortical carcinoma. Unlike general chemotherapy, Mitotane directly affects the adrenal cortex, helping to:
- Reduce abnormal hormone production
- Slow down cancer cell growth
This makes Mitotane both a cancer therapy and a hormone management tool, addressing two key challenges of ACC.
How Mitotane Helps Patients
- Targeted Effect – Works at the adrenal gland level to reduce excess hormone activity.
- Supports Long-Term Care – Helps keep cancer under control, improving long-term outcomes.
- Improves Quality of Life – By restoring hormone balance, it may reduce symptoms such as weight changes, fatigue, or high blood pressure.
- Recognized Worldwide – Mitotane is established as the standard treatment for ACC in many international guidelines.
Important Information for Patients
- How It’s Taken: Mitotane is provided in tablet form and taken orally under a doctor’s supervision.
- Monitoring Is Key: Blood levels of Mitotane are checked regularly to make sure the dose is safe and effective.
- Possible Side Effects: Some patients may experience nausea, dizziness, or tiredness. These effects are closely managed by healthcare teams.
- Individualized Treatment: Every patient’s therapy is adjusted based on their needs, tolerance, and treatment goals.
Our Commitment
At LUCIUS PHARMACEUTICALS (LAO) CO., LTD, we understand the uncertainty that comes with a rare cancer diagnosis. That’s why we are committed to:
- Reliable Access – Ensuring patients can obtain Mitotane through trusted medical channels.
- Educational Guidance – Providing clear, science-based information to help patients and families feel informed and supported.
- Partnership with Doctors – Working hand‑in‑hand with healthcare providers to achieve the best outcomes possible.
Final Message
Mitotane is more than a medicine—it is a proven advancement in adrenal cancer care. By slowing disease progression and managing hormone-related complications, it offers patients and families a stronger path forward.
At LUCIUS PHARMACEUTICALS (LAO) CO., LTD, we remain committed to innovation, patient support, and global collaboration in the fight against adrenal cortical carcinoma.
